(BNR) – Company Press Releases
-
Burning Rock Reports Fourth Quarter and Full Year 2023 Financial Results
-
Burning Rock Announces Results of 2023 Annual General Meeting
-
Burning Rock Announces 2023 Annual General Meeting to be Held on December 20, 2023
-
Burning Rock Schedules Third Quarter of 2023 Earnings Release on November 30, 2023
-
Burning Rock Received Breakthrough Device Designation from China’s NMPA for its Multi-Cancer Early Detection Test
-
Burning Rock's minimal residual disease (MRD) product supports advancement in early-stage non-small cell lung cancer treatment, with results published in the Cancer Cell
-
Burning Rock Provides Second Quarter 2023 Business Updates and Schedules Earnings Release on August 31, 2023
-
Burning Rock Announces Resignation and Appointment of Directors
-
Burning Rock's precision oncology diagnostics product supports advancement in late-stage breast cancer treatment, with results published in the New England Journal of Medicine
-
Burning Rock Reports First Quarter 2023 Financial Results
-
Burning Rock Provides First Quarter 2023 Business Updates and Schedules Earnings Release on May 30, 2023
-
Burning Rock Publishes 2022 Annual Report on Form 20-F
-
Burning Rock Reports Fourth Quarter and Full Year 2022 Financial Results
-
Burning Rock Schedules Fourth Quarter and Full Year 2022 Earnings Release on March 28, 2023
-
Burning Rock provides an update on 2022 revenue guidance
-
Burning Rock Received FDA Breakthrough Device Designation for its OverC™ Multi-Cancer Detection Blood Test
-
Burning Rock Received FDA Breakthrough Device Designation for its OverC™ Multi-Cancer Detection Blood Test
-
Burning Rock Received FDA Breakthrough Device Designation for its OverC™ Multi-Cancer Detection Blood Test
-
Burning Rock Reports Third Quarter 2022 Financial Results
-
Admission to Trading on the London Stock Exchange
-
Admission to Trading on the London Stock Exchange
-
Burning Rock Announces Publication of Prospectus in connection with Direct Listing on the London Stock Exchange
-
Burning Rock Announces Publication of Prospectus in connection with Direct Listing on the London Stock Exchange
-
Burning Rock Provides Third Quarter 2022 Business Updates and Schedules Earnings Release on November 16, 2022
-
Burning Rock Provides Third Quarter 2022 Business Updates and Schedules Earnings Release on November 16, 2022
-
Burning Rock Announces Publication of Registration Document and Potential Direct Listing on the London Stock Exchange
-
Burning Rock Announces Publication of Registration Document and Potential Direct Listing on the London Stock Exchange
-
Worldwide Liquid Biopsy (LBx) Market Forecasted to Grow at 46% p.a., Reaching $8.6B by 2027 – Market Report by DeciBio Consulting LLC
-
Burning Rock Announces Results of 2022 Annual General Meeting
-
Burning Rock Announces Results of 2022 Annual General Meeting
-
Burning Rock Reports Second Quarter 2022 Financial Results
-
Burning Rock Reports Second Quarter 2022 Financial Results
-
Burning Rock Provides Second Quarter 2022 Business Updates and Schedules Earnings Release on August 31, 2022
-
Burning Rock Provides Second Quarter 2022 Business Updates and Schedules Earnings Release on August 31, 2022
-
Burning Rock Announces 2022 Annual General Meeting to be Held on September 8, 2022
-
Burning Rock Announces 2022 Annual General Meeting to be Held on September 8, 2022
-
Burning Rock Announces Resignation of Director
-
Burning Rock Announces Resignation of Director
-
Burning Rock Announces the Launch of China’s First Prospective Interventional Validation Study on Multi-Cancer Early Detection - the PREVENT Study
-
Burning Rock Announces the Launch of China’s First Prospective Interventional Validation Study on Multi-Cancer Early Detection - the PREVENT Study
-
Burning Rock Announces Changes to Board Composition
-
Burning Rock Announces Changes to Board Composition
-
Burning Rock Announces US$10 Million Share Repurchase Program
-
Burning Rock Announces US$10 Million Share Repurchase Program
-
Burning Rock Announces Plan to Pursue An Alternative Listing
-
Burning Rock Announces Plan to Pursue An Alternative Listing
-
Burning Rock Presents Latest Clinical Data from THUNDER Study at 2022 ASCO Annual Meeting
-
Burning Rock Receives CE Mark for its OverC™ Multi-Cancer Detection Blood Test Kit
-
Burning Rock Reports First Quarter 2022 Financial Results
-
Burning Rock Reports First Quarter 2022 Financial Results
Back to BNR Stock Lookup